Page last updated: 2024-10-27

fluoxetine and Cocarcinogenesis

fluoxetine has been researched along with Cocarcinogenesis in 2 studies

Fluoxetine: The first highly specific serotonin uptake inhibitor. It is used as an antidepressant and often has a more acceptable side-effects profile than traditional antidepressants.
fluoxetine : A racemate comprising equimolar amounts of (R)- and (S)-fluoxetine. A selective serotonin reuptake inhibitor (SSRI), it is used (generally as the hydrochloride salt) for the treatment of depression (and the depressive phase of bipolar disorder), bullimia nervosa, and obsessive-compulsive disorder.
N-methyl-3-phenyl-3-[4-(trifluoromethyl)phenoxy]propan-1-amine : An aromatic ether consisting of 4-trifluoromethylphenol in which the hydrogen of the phenolic hydroxy group is replaced by a 3-(methylamino)-1-phenylpropyl group.

Cocarcinogenesis: The combination of two or more different factors in the production of cancer.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Miller, LG1
Lin, X1
Levitsky, DA1
King, JM1
Campbell, TC1

Other Studies

2 other studies available for fluoxetine and Cocarcinogenesis

ArticleYear
Antidepressants and cancer: cause for concern?
    Journal of clinical psychopharmacology, 1993, Volume: 13, Issue:1

    Topics: Amitriptyline; Animals; Antidepressive Agents; Cocarcinogenesis; Depressive Disorder; Fluoxetine; Hu

1993
The promotion effect of anorectic drugs on aflatoxin B(1)-induced hepatic preneoplastic foci.
    Carcinogenesis, 1999, Volume: 20, Issue:9

    Topics: Adipose Tissue, Brown; Aflatoxin B1; Amphetamine; Animals; Appetite Depressants; Biomarkers; Body Te

1999